Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

610 Press Releases
DateTitleCompany
06 Oct 11 Merck Announces Retirement of Chairman and Former CEO Richard T. Clark Merck,
Published by
Business Wire
05 Oct 11 FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor Merck and ARIAD Pharmaceuticals Inc.,
Published by
Business Wire
30 Sep 11 Merck Announces New Data Analyses for VICTRELIS™ (boceprevir) will be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting Merck & Co. Inc.,
Published by
Business Wire
30 Sep 11 Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28 Merck,
Published by
Business Wire
29 Sep 11 Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals Merck,
Published by
Business Wire
28 Sep 11 Merck Serono extends funding for KRAS tests to all UK colorectal cancer (CRC) patients Merck Serono
27 Sep 11 Merck Names Cuong Viet Do as Chief Strategy Officer Merck,
Published by
Business Wire
26 Sep 11 Merck Serono: New Data Inspire Global Experts to Call for Improved Education, Awareness and Support for Head and Neck Cancer Patients Merck Serono,
Published by
Business Wire
20 Sep 11 New Data on Odanacatib, Merck’s Phase III Investigational Cat-K Inhibitor for Osteoporosis, Presented at the Annual Meeting of The American Society for Bone and Mineral Research Merck & Co. Inc.,
Published by
Business Wire
19 Sep 11 Merck’s ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Efficacy and Tolerability in an Observational Trial in a Diverse Population of Adults with HIV-1 Regardless of Gender or Race Merck,
Published by
Business Wire
14 Sep 11 Merck to Present at Bank of America Merrill Lynch Global Healthcare Conference Merck,
Published by
Business Wire
14 Sep 11 Merck Statement on GARDASIL® Merck,
Published by
Business Wire
13 Sep 11 Merck Partners with Susan G. Komen for the Cure® on Historic Initiative to Help Address Cervical and Breast Cancer in Developing Nations Merck,
Published by
Business Wire
13 Sep 11 Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies Merck and BGI,
Published by
Business Wire
12 Sep 11 Merck to Present at Morgan Stanley Global Healthcare Conference Merck,
Published by
Business Wire
30 Aug 11 Merck Millipore Strengthens Bioscience Business by acquiring Amnis Corporation Merck Millipore,
Published by
Business Wire
24 Aug 11 Merck Appoints Richard R. DeLuca Jr. as President, Merck Animal Health Merck,
Published by
PharmiWeb.com
18 Aug 11 Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus, Investigational mTOR Inhibitor Merck,
Published by
Business Wire
03 Aug 11 Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV) Merck,
Published by
Business Wire
29 Jul 11 Merck Announces Second Quarter 2011 Financial Results Merck & Co. Inc.,
Published by
Business Wire
27 Jul 11 Merck Announces Fourth Quarter 2011 Dividend Merck,
Published by
Business Wire
22 Jul 11 Merck and Simcere Sign Agreement to Establish Pioneering China Joint Venture Merck & Co. Inc.,
Published by
Business Wire
20 Jul 11 Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C Merck,
Published by
Business Wire
18 Jul 11 VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C Merck,
Published by
Business Wire
18 Jul 11 Merck’s ISENTRESS® (raltegravir) in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 Merck,
Published by
Business Wire
11 Jul 11 Merck to Participate in New Research Efforts to Eradicate HIV Merck,
Published by
Business Wire
02 Jul 11 CORRECTING and REPLACING Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan Merck & Co. Inc.,
Published by
Business Wire
01 Jul 11 Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan Merck & Co. Inc.,
Published by
Business Wire
30 Jun 11 Merck to Hold Second-Quarter 2011 Sales and Earnings Conference Call on July 29 Merck,
Published by
Business Wire
28 Jun 11 UPS and Merck Expand Their Distribution and Logistics Agreement Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.